Bo‐Hyun Cho

Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions

Bo‐Hyun Cho, Charles Stoecker, Ruth Link‐Gelles et al. · Vaccine · 2013 · 74 citations

Veterinary Medicine, Immunology, Pharmacoeconomics +15

Cost-effectiveness of continuing pneumococcal conjugate vaccination at age 65 in the context of indirect effects from the childhood immunization program

Charles Stoecker, Miwako Kobayashi, Almea Matanock et al. · Vaccine · 2019 · 45 citations

Medicine, Pediatrics, Pharmacoeconomics +17

Impact and cost-effectiveness of a second tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine dose to prevent pertussis in the United States

Hajime Kamiya, Bo‐Hyun Cho, Mark L. Messonnier et al. · Vaccine · 2016 · 24 citations

Veterinary Medicine, Infectious Diseases, Pharmacoeconomics +17

Public health impact and cost-effectiveness of 15-valent pneumococcal conjugate vaccine use among the pediatric population of the United States

Namrata Prasad, Charles Stoecker, Wei Xing et al. · Vaccine · 2023 · 19 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Influenza vaccination coverage rate among high-risk children during the 2002-2003 influenza season

Bo‐Hyun Cho, Maureen Kolasa, Mark L. Messonnier · American Journal of Infection Control · 2008 · 16 citations

Medicine, Child Health, Pediatrics +16